Brooks Laboratories Limited (BROOKS) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.003x

Based on the latest financial reports, Brooks Laboratories Limited (BROOKS) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs3.19 Million ≈ $34.55K USD) by net assets (Rs1.16 Billion ≈ $12.51 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Brooks Laboratories Limited - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Brooks Laboratories Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read BROOKS current and long-term liabilities for a breakdown of total debt and financial obligations.

Brooks Laboratories Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Brooks Laboratories Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Coffee Holding Co Inc NASDAQ:JVA	0.014x
HEBEI YICHEN GRP H YC 05 F:HE2	N/A
Talius Group Ltd. AU:TAL	-0.265x
Linkhome Holdings Inc. Common stock NASDAQ:LHAI	-0.431x
Japan Vietnam Medical Instrument JSC VN:JVC	0.005x
Alphawave IP Group PLC LSE:AWE	-0.107x
Alton Sports Co.Ltd KQ:123750	0.190x
Modernland Realty Ltd Tbk JK:MDLN	0.000x

Annual Cash Flow Conversion Efficiency for Brooks Laboratories Limited (2007–2025)

The table below shows the annual cash flow conversion efficiency of Brooks Laboratories Limited from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see BROOKS company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs981.04 Million ≈ $10.61 Million	Rs17.62 Million ≈ $190.59K	0.018x	+112.17%
2024-03-31	Rs655.85 Million ≈ $7.09 Million	Rs-96.81 Million ≈ $-1.05 Million	-0.148x	+24.67%
2023-03-31	Rs739.53 Million ≈ $8.00 Million	Rs-144.91 Million ≈ $-1.57 Million	-0.196x	+29.70%
2022-03-31	Rs1.34 Billion ≈ $14.53 Million	Rs-374.41 Million ≈ $-4.05 Million	-0.279x	-594.81%
2021-03-31	Rs791.48 Million ≈ $8.56 Million	Rs44.59 Million ≈ $482.19K	0.056x	+159.05%
2020-03-31	Rs984.16 Million ≈ $10.64 Million	Rs-93.89 Million ≈ $-1.02 Million	-0.095x	-98.66%
2019-03-31	Rs1.05 Billion ≈ $11.37 Million	Rs-50.49 Million ≈ $-546.08K	-0.048x	+11.07%
2018-03-31	Rs1.14 Billion ≈ $12.38 Million	Rs-61.81 Million ≈ $-668.48K	-0.054x	-169.74%
2017-03-31	Rs1.24 Billion ≈ $13.41 Million	Rs96.01 Million ≈ $1.04 Million	0.077x	+16.39%
2016-03-31	Rs1.22 Billion ≈ $13.20 Million	Rs81.19 Million ≈ $878.02K	0.067x	+248.09%
2015-03-31	Rs1.11 Billion ≈ $12.05 Million	Rs21.29 Million ≈ $230.26K	0.019x	-81.66%
2014-03-31	Rs1.12 Billion ≈ $12.14 Million	Rs116.98 Million ≈ $1.27 Million	0.104x	+103.74%
2013-03-31	Rs1.05 Billion ≈ $11.40 Million	Rs53.90 Million ≈ $582.89K	0.051x	+361.70%
2012-03-31	Rs912.63 Million ≈ $9.87 Million	Rs-17.83 Million ≈ $-192.84K	-0.020x	-109.59%
2011-03-31	Rs194.27 Million ≈ $2.10 Million	Rs39.59 Million ≈ $428.16K	0.204x	-51.15%
2010-03-31	Rs136.42 Million ≈ $1.48 Million	Rs56.91 Million ≈ $615.45K	0.417x	+144.20%
2009-03-31	Rs85.37 Million ≈ $923.22K	Rs14.58 Million ≈ $157.71K	0.171x	-58.33%
2008-03-31	Rs49.11 Million ≈ $531.11K	Rs20.13 Million ≈ $217.73K	0.410x	+565.61%
2007-03-31	Rs17.58 Million ≈ $190.16K	Rs1.08 Million ≈ $11.71K	0.062x	--

About Brooks Laboratories Limited

NSE:BROOKS India Drug Manufacturers - Specialty & Generic

Market Cap

$17.83 Million

Rs1.65 Billion INR

Market Cap Rank

#25384 Global

#1413 in India

Share Price

Rs55.98

Change (1 day)

-4.89%

52-Week Range

Rs37.11 - Rs161.50

All Time High

Rs194.97